2002
Session to Improve Knowledge and Practices to Help Overcome Rising Mortality Rate Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
New Technology May Reduce Risk of Major Complications Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
Guidant Expands Agreement with Novartis Pharma AG Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today...
Company Reiterates Guidance for 2002; Previews 2003 Full-Year Revenue and Earnings Per Share New York - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
Sixth-Generation MULTI-LINK Stent System Features Enhanced Deliverability, Market-Leading Stent Design Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...
Vulnerable Plaque Presents Significant Opportunity for Preventive Treatment Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
Approval Affirms Momentum of Breakthrough Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that the...
Company Raises Third Quarter 2002 Sales and Earnings Per Share Guidance Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
New System Enhances Physician''s Ability to Navigate Challenging Anatomy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...